BIOPHARM · BIO

BIOPHARM is an Algerian pharmaceutical group active across several parts of the healthcare value chain. The company manufactures pharmaceutical products, imports and distributes medicines, promotes healthcare products, and operates logistics and wholesale distribution activities that connect manufacturers, pharmacies, hospitals, and healthcare institutions. Its business is supported by structural demand for medicines, population health needs, domestic production policies, distribution scale, regulatory approvals, supplier relationships, and the ability to maintain reliable access to essential and specialty products. BIOPHARM's integrated model gives it exposure to both pharmaceutical manufacturing and commercial distribution, while also requiring quality control, compliance with health regulations, working-capital discipline, and effective management of inventories and supplier terms. As a listed company on the Algiers Stock Exchange, BIOPHARM provides investors with exposure to Algeria's healthcare and pharmaceutical sector, including local production capacity, medicine distribution networks, and the modernization of regulated healthcare supply chains. Its long-term profile is tied to drug demand, industrial investment, reimbursement and pricing frameworks, and operational execution.